Journal of Cancer Genetics And Biomarkers

Journal of Cancer Genetics And Biomarkers

Journal of Cancer Genetics and Biomarkers (JCGB) is an open-access, peer-reviewed journal dedicated to advancing the field of cancer genetics and biomarkers. Focused on the molecular mechanisms of tumorigenesis, gene expression, genomics, epigenetics, and proteomics, the journal publishes original research, comprehensive reviews, and thought-provoking opinion articles. By fostering the exchange of cutting-edge knowledge, JCGB aims to contribute to the development of innovative cancer diagnostics, therapeutics, and prevention strategies. 

Note: An Article Processing Charge (APC) is levied to authors to make a research work available open access in Journal of Cancer Genetics And Biomarkers.

Submit Manuscript

Journal metrics

Short code

JCGB

ISSN

2572-3030

Average Processing Time

25 days

Acceptance rate

59%

Submission to first decision

12 days

Acceptance to publication

2 days

JCGB-IF

6.042

Our Specialties

Journal of Cancer Genetics And Biomarkers is a comprehensive, peer-reviewed journal that helps disseminate original research work, having a unique aspect of covering many areas which contributes to providing an awareness of research studies of scientists around the globe.

Constant Updating

About: The Journal of Cancer Genetics and Biomarkers is a leading publication dedicated to advancing the understanding of cancer genetics and biomarkers. It provides a platform for researchers, clinicians, and scientists to share cutting-edge discoveries and insights in the field of cancer genetics and biomarkers.

About

Avg Processing Time: JCGB provides an efficient submission process, with an average processing time of 28 days that prioritizes swift dissemination of groundbreaking research. Authors can expect prompt and transparent communication throughout the submission and review process, ensuring a seamless publication experience.

Editorial board

Advanced Online Editorial Manager
High Quality Peer review

Peer Reviewed: All submissions undergo rigorous peer review by experts in the field, ensuring the highest quality and integrity of published research. Our commitment to maintaining rigorous peer review standards ensures that only the most impactful and scientifically sound studies are published.

Peer Review

Archives: The Journal of Cancer Genetics and Biomarkers boasts a comprehensive archive of past issues, providing a valuable resource for researchers and practitioners seeking historical perspectives and foundational knowledge in cancer genetics and biomarkers. Our archives are easily accessible, allowing readers to delve into a wealth of valuable content.

Archives

Easy-to-Use Search Functionalities
Article Email Facility

High Visibility: Our journal offers high visibility and global reach, ensuring that groundbreaking research in cancer genetics and biomarkers reaches a wide audience of experts and stakeholders. With a strong online presence and indexing in major databases, our articles are easily accessible and widely cited.

Open Access

Membership: Our journal offers membership opportunities for researchers, clinicians, and professionals in the field of cancer genetics and biomarkers. Membership provides exclusive benefits such as discounts on publication fees, fostering a vibrant community of experts dedicated to advancing the field.

Membership

SEO

Editorial Board

Cancer Genetics And Biomarkers-Cancer Biologist and Drug Discovery Expert-Joshua Curtin

Dr. Joshua Curtin

Route 206 and Provinceline Road Princeton, NJ 08540, USA, 616 Corporate Way Suite 2-6158, Valley Cottage, New York, United States.

View Profile
Cancer Genetics And Biomarkers-Molecular aspects of colorectal cancer (PS3-Runjan Chetty

Dr. Runjan Chetty

11th floor, Eaton wing, Toronto General Hospital.

View Profile
Cancer Genetics And Biomarkers-Ovarian cancer is the fourth most common cause of female cancer death in the UK.-Charlie Gourley

Dr. Charlie Gourley

Chair of Medical Oncology, Honorary Consultant in Medical Oncology, Edinburgh Cancer Research Centre, Western General Hospital, UK

View Profile
Cancer Genetics And Biomarkers-Potential clinical use of biomarkers of oxidative DNA damage and systems of reparation.-Krzysztof Roszkowski

Dr. Krzysztof Roszkowski

Romanowskiej 2,  Bydgoszcz 85-796,  Poland.

View Profile

Recent Articles

Article: High-Throughput Complex Disease Modeling for Ethical Drug Discovery: Clinical Relevance of a NAM Platform for Cancer Biomarker Development
Cancer Genetics And Biomarkers

High-Throughput Complex Disease Modeling for Ethical Drug Discovery: Clinical Relevance of a NAM Platform for Cancer Biomarker Development

Read the full article
Article: Dynamic MicroRNA-Expression in Plasma of Melanoma Patients Correlates With Progression, PD-L1 Status and Overall Survival
Cancer Genetics And Biomarkers

Dynamic MicroRNA-Expression in Plasma of Melanoma Patients Correlates With Progression, PD-L1 Status and Overall Survival

Read the full article
Article: Correlating 13C Isotope in Oligomeric Proanthocyanidins with their Anticancer Properties
Cancer Genetics And Biomarkers

Correlating 13C Isotope in Oligomeric Proanthocyanidins with their Anticancer Properties

Read the full article
Article: Targeting Mutational Landscape of TP53 in patients diagnosed with Oral Cancer living in Senegal
Cancer Genetics And Biomarkers

Targeting Mutational Landscape of TP53 in patients diagnosed with Oral Cancer living in Senegal

Read the full article
SUBMIT MANUSCRIPT NOW